# Mdsim

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mdsim

- Industry: Healthcare IT
- Headquarters: Esch-sur-Alzette, Luxembourg
- Website: www.mdsim.net
- Total disclosed funding: $2.1M
- Latest round: Seed (Jan 31, 2025)
- Investors on record: 3

## About

Based in Luxembourg, Mdsim operates as a healthcare technology company focused on advanced simulation and analytics to improve spine care outcomes through innovative digital solutions.Mdsim, founded in 2022 in Esch-sur-Alzette, Luxembourg, specializes in healthcare technology, particularly in spine surgery. The company has completed one deal to date. In March 2025, Mdsim raised EUR 1.7 million in Seed funding led by Kadmos Capital, with participation from the King Baudouin Foundation. The total amount raised by the company is EUR 1.7 million, resulting in a current company valuation of EUR 14.2 million.Mdsim specializes in advanced healthcare solutions centered around its flagship product, the SPINEsim Software-as-Medical Device Platform. This platform employs data, computer modeling, simulation, and artificial intelligence to create patient-specific biomechanical digital twins of the spine. The primary aim is to empower clinicians, particularly spine surgeons, and patients in assessing, preventing, and planning optimal surgical interventions for conditions such as aging, osteoporosis, scoliosis, trauma, and tumors that lead to spinal degeneration and deformity. By facilitating a comprehensive analysis of spine health and providing simulation capabilities, SPINEsim serves a diverse clientele, including healthcare professionals and patients actively seeking superior spine care, targeting markets with significant aging populations like North America, Europe, and parts of Asia.Mdsim generates revenue primarily through subscriptions to its SPINEsim platform, targeting healthcare institutions and individual clinicians. Clients engage with the platform to access advanced simulation tools that assist in planning spine surgeries and tracking patient progress. The transaction structure is designed to foster long-term partnerships with medical professionals, allowing for ongoing access to the platform in exchange for a subscription fee. The pricing model reflects the value provided through high-fidelity simulations and tailored insights, enabling clinicians to optimize surgical outcomes effectively, particularly in markets with a rising elderly demographic.In March 2025, Mdsim raised EUR 1.7 million in Seed funding, led by Kadmos Capital, to advance the deployment of patient-specific digital twin technologies to support clinical decision-making in spine surgery. The company is focused on expanding its product offerings and aims to enhance the capabilities of its SPINEsim platform to meet the growing needs in spine care. Mdsim's strategic plans also include targeting expansion into new regions with a focus on healthcare markets in North America and Europe, aligning with the increasing demands for advanced spine healthcare solutions.

## Funding rounds

- Seed, Jan 31, 2025, $2.1M — Astorg, iPoint-systems gmbh, Kadmos Capital

## Investors

- Astorg (https://capitalatlas.ai/funds/astorg) — Seed
- iPoint-systems gmbh — Seed
- Kadmos Capital (https://capitalatlas.ai/funds/kadmos-capital) — Seed